Reset
Showing 4 of 4 academic articles

siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases

Tutu Kalita, Saba Abbasi Dezfouli, Lalit M. Pandey, Hasan Uludag • Pharmaceutics (2022)

RNAi (RNA interference)-based technology is emerging as a versatile tool which has been widely utilized in the treatment of various diseases. siRNA can alter gene expression by binding to the target mRNA and thereby inhibiting its translati...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14112520

Enteric Coating Enhances the Biopharmaceutical Performance of a Silica–Lipid Formulation of Abiraterone Acetate

Ali Taheri, Ruba Almasri, Anthony Wignall, Felicia Feltrin et al. • Pharmaceutics (2025)

Background/Objectives: Lipid-based formulations are widely used to enhance the oral bioavailability of poorly water-soluble drugs. However, for weakly basic drugs with higher solubility under acidic conditions, precipitation and recrystalli...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics17101289

Characterization data on the topical carrier DDC642

Eline Desmet, Stefanie Bracke, Katrien Forier, Lien Taevernier et al. • Data in Brief (2016)

This article contains original data, figures and methods used in the characterization of the liposomal carrier ‘DDC642’ for topical applications, described in “An elastic liposomal formulation for RNAi-based topical treatment of skin disord...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.dib.2016.03.091

<i>In-House</i> Innovative “Diamond Shaped” 3D Printed Microfluidic Devices for Lysozyme-Loaded Liposomes

Federica Sommonte, Edward Weaver, Essyrose Mathew, Nunzio Denora et al. • Pharmaceutics (2022)

Nanotechnology applications have emerged as one of the most actively researched areas in recent years. As a result, substantial study into nanoparticulate lipidic systems and liposomes (LPs) has been conducted. Regardless of the advantages,...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14112484